Results 261 to 270 of about 80,266 (330)

Bruton's Agammaglobulinemia: Case Series and Literature Review From King Fahad Central Hospital, Jizan, Saudi Arabia. [PDF]

Am J Case Rep
Shamakhi A, Dhayhi N, Matabi S, Maashi M, Hamdi AD, Ali B, Hazazi F, Alhamoud AH.   +7 more
europepmc   +1 more source

BTK autoinhibition analyzed by high-throughput swaps of SH2 domains. [PDF]

Proc Natl Acad Sci U S A
Eisen TJ, Ghaffari-Kashani S, Hung CL, Groves JT, Kuriyan J.   +4 more
europepmc   +1 more source

Energigräsutveckling i USA [PDF]

, 2001
Olsson (BTK), Rolf
core  

The Direction of Modern Therapies in Waldenström Macroglobulinaemia. [PDF]

J Cell Mol Med
Blackmore S, Elsawa S, Tavana O.
europepmc   +1 more source

Author Response: Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states

David Yin-wei Lin, Lauren E. Kueffer, Puneet Juneja, Thomas E. Wales, John R. Engen, Amy H. Andreotti   +5 more
openalex   +1 more source

Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression. [PDF]

Blood Cancer J
Tantawy SI, Aslan B, Manyam G, Iles LR, Timofeeva N, Singh N, Jain N, Ferrajoli A, Thompson PA, Patel KP, Desikan SP, Wierda WG, Gandhi V.   +12 more
europepmc   +1 more source

BTK Inhibitor LOXO-305 [PDF]

, 2020
openaire   +1 more source

Whole Genome Sequencing in 25 Families with Suspected Inborn Errors of Immunity: Diagnostic Yield and Clinical Relevance of Genome-wide Analysis. [PDF]

J Clin Immunol
Lee JK, Jang JH, Kim DR, Shin A, Park JH, Kim YG, Kim JW, Kim YJ, Kang ES.   +8 more
europepmc   +1 more source

A quantitative mechanistic PK/PD model directly connects Btk target engagement and in vivo efficacy

, 2017
Fereidoon Daryaee, Zhuo Zhang, Kayla R. Gogarty, Yong Li, Jonathan Merino, Stewart L. Fisher, Peter J. Tonge   +6 more
openalex   +2 more sources